Valuation: Coral Laboratories Limited

Market Cap 1.32B 13.88M 12.03M 11.27M 10.28M 19.32M 19.62M 133M 51.8M 663M 52.11M 50.98M 2.21B P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 1.05B 11.01M 9.54M 8.94M 8.15M 15.32M 15.56M 105M 41.08M 526M 41.33M 40.43M 1.75B EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.97%
Yield 2024
0.54%
Yield 2025 0.21%
1 day+1.18%
1 week+2.98%
Current month+0.82%
1 month-3.44%
3 months+34.24%
6 months+18.96%
Current year+32.05%
1 week 540
Extreme 540
604.85
1 month 540
Extreme 540
615
Current year 360
Extreme 360
659
1 year 360
Extreme 360
659
3 years 251.1
Extreme 251.1
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 26/05/2017
Director TitleAgeSince
Director/Board Member 45 26/05/2017
Director/Board Member 49 26/05/2017
Director/Board Member 40 28/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%+2.98%+4.23%+119.34% 21.44M
+0.43%+4.31%+90.84%+130.99% 1,083B
+0.41%+1.27%+50.98%+50.05% 626B
-0.53%+1.04%+25.23%+63.46% 442B
-0.92%+0.22%+48.34%+37.85% 363B
-1.32%-0.21%+29.07%+36.81% 295B
-1.20%-2.78%+5.56%+6.09% 248B
+0.45%+2.05%+46.04%+58.54% 224B
-2.51%+1.77%-6.55%-51.74% 210B
+0.07%+3.12%+13.21%+69.84% 168B
Average -0.39%+1.32%+30.69%+52.12% 365.91B
Weighted average by Cap. -0.26%+2.19%+49.22%+65.96%

Financials

2024 2025
Net sales 837M 8.77M 7.6M 7.12M 6.49M 12.21M 12.4M 83.75M 32.74M 419M 32.93M 32.22M 1.4B 1.15B 12.06M 10.45M 9.79M 8.93M 16.78M 17.04M 115M 45M 576M 45.27M 44.29M 1.92B
Net income 158M 1.66M 1.43M 1.34M 1.23M 2.3M 2.34M 15.81M 6.18M 79.06M 6.22M 6.08M 264M 242M 2.53M 2.19M 2.06M 1.88M 3.53M 3.58M 24.18M 9.45M 121M 9.51M 9.3M 403M
Net Debt -278M -2.91M -2.52M -2.36M -2.16M -4.06M -4.12M -27.81M -10.87M -139M -10.94M -10.7M -464M -274M -2.87M -2.49M -2.33M -2.13M -4M -4.06M -27.42M -10.72M -137M -10.78M -10.55M -457M
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
12/08/26 ₹579.05 +1.18% 837
11/08/26 ₹572.30 -0.97% 1,429
07/08/26 ₹577.90 +3.57% 583
06/08/26 ₹558.00 -0.76% 368
05/08/26 ₹562.30 -2.21% 167
  1. Stock Market
  2. Stocks
  3. 524506 Stock